Thomas A Hope Selected Research

gallium 68 PSMA-11

11/2022	The PRIMARY Score: Using Intraprostatic 68Ga-PSMA PET/CT Patterns to Optimize Prostate Cancer Diagnosis.
1/2022	A Comprehensive Assessment of 68Ga-PSMA-11 PET in Biochemically Recurrent Prostate Cancer: Results from a Prospective Multicenter Study on 2,005 Patients.
11/2021	Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection: A Multicenter Prospective Phase 3 Imaging Trial.
12/2020	Factors Predicting Metastatic Disease in 68Ga-PSMA-11 PET-Positive Osseous Lesions in Prostate Cancer.
12/2020	Impact of 68Ga-PSMA-11 PET on the Management of Recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial.
6/2019	Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial.
1/2019	Intertumoral Heterogeneity of 18F-FDG and 68Ga-PSMA Uptake in Prostate Cancer Pulmonary Metastases.
1/2019	Single-Center Prospective Evaluation of 68Ga-PSMA-11 PET in Biochemical Recurrence of Prostate Cancer.
1/2019	Solitary Mucinous Prostate Adenocarcinoma Lung Metastasis Detected by 68Ga-PSMA-11 PET/CT.
1/2019	Impact of Staging 68Ga-PSMA-11 PET Scans on Radiation Treatment Plansin Patients With Prostate Cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas A Hope Research Topics

Disease

42	Prostatic Neoplasms (Prostate Cancer) 11/2022 - 06/2015
16	Neoplasms (Cancer) 06/2022 - 11/2012
10	Neuroendocrine Tumors (Neuroendocrine Tumor) 06/2022 - 08/2015
10	Neoplasm Metastasis (Metastasis) 11/2021 - 06/2015
5	Primary Hyperparathyroidism 01/2022 - 01/2016
4	Adenocarcinoma 01/2022 - 06/2015
4	Hepatocellular Carcinoma (Hepatoma) 11/2016 - 01/2016
4	Nephrogenic Fibrosing Dermopathy 01/2013 - 03/2009
3	Body Weight (Weight, Body) 06/2015 - 11/2009
2	Inflammation (Inflammations) 12/2021 - 08/2012
2	Parathyroid Neoplasms (Parathyroid Neoplasm) 11/2021 - 01/2021
2	Hyperparathyroidism 01/2021 - 01/2017
2	Fibrosis (Cirrhosis) 07/2014 - 08/2012
1	Infections 01/2022
1	Paraganglioma (Paragangliomas) 01/2021
1	Pheochromocytoma 01/2021
1	Thyroid Neoplasms (Thyroid Cancer) 10/2020
1	COVID-19 08/2020
1	Pain (Aches) 11/2019
1	Colorectal Neoplasms (Colorectal Cancer) 08/2019
1	Pituitary Neoplasms (Pituitary Adenoma) 01/2019
1	Thyroid Dysgenesis (Thyroid Agenesis) 01/2019
1	Adenocarcinoma of Lung 01/2019
1	Squamous Cell Carcinoma of Head and Neck 04/2017
1	Carcinoma (Carcinomatosis) 04/2017
1	Hemangioma (Angioma) 06/2016
1	Anemia 05/2016
1	Liver Diseases (Liver Disease) 01/2016
1	Renal Insufficiency (Renal Failure) 09/2015
1	Hypersensitivity (Allergy) 06/2015
1	Acquired Immunodeficiency Syndrome (AIDS) 11/2014

Drug/Important Bio-Agent (IBA)

26	AntigensIBA 01/2022 - 08/2016
19	gallium 68 PSMA-11IBA 11/2022 - 01/2017
10	Radioisotopes (Radionuclides)IBA 06/2022 - 11/2014
8	Peptide Receptors (Peptide Receptor)IBA 06/2022 - 01/2019
8	LigandsIBA 01/2022 - 08/2016
7	RadiopharmaceuticalsIBA 06/2022 - 01/2019
6	Prostate-Specific Antigen (Semenogelase)IBA 01/2022 - 04/2017
5	Somatostatin Receptors (Somatostatin Receptor)IBA 06/2022 - 06/2015
5	fluorocholineIBA 01/2022 - 01/2017
5	AndrogensIBA 12/2019 - 06/2015
5	Contrast MediaIBA 06/2016 - 06/2015
4	gadolinium ethoxybenzyl DTPA FDA Link 06/2016 - 08/2012
3	Technetium Tc 99m Sestamibi (Cardiolite)FDA LinkGeneric 11/2021 - 01/2017
3	gadodiamide (Omniscan)FDA Link 01/2016 - 11/2009
3	IronIBA 07/2014 - 11/2009
2	Lutetium-177IBA 06/2022 - 01/2022
2	lutetium Lu 177 dotatateIBA 01/2021 - 01/2019
2	Choline (Choline Chloride)IBA 01/2021 - 01/2018
2	Gallium-68IBA 10/2020 - 01/2019
2	Hormones (Hormone)IBA 08/2019 - 01/2019
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2019 - 06/2015
2	gallium Ga 68 dotatateIBA 01/2019 - 01/2019
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2019 - 01/2018
2	GalliumIBA 01/2019 - 12/2018
2	PSMA-11IBA 01/2019 - 01/2019
2	Ferrosoferric Oxide (Magnetite)FDA Link 05/2016 - 09/2015
2	GadoliniumIBA 09/2015 - 08/2012
2	Erythropoietin FDA Link 01/2013 - 11/2009
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	DOTA-Tyr(3)- 90Y-octreotideIBA 01/2021
1	Ga(III)-DOTATOCIBA 01/2021
1	CarbonIBA 01/2021
1	FluorineIBA 01/2021
1	Formaldehyde (Formol)FDA Link 08/2019
1	ParaffinIBA 08/2019
1	Estrogen Receptor alphaIBA 08/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	Biological ProductsIBA 01/2019
1	Abiraterone AcetateIBA 01/2019
1	Boronic AcidsIBA 01/2019
1	BoronIBA 01/2019
1	phosphoramidic acidIBA 01/2019
1	Edotreotide (SMT 487)IBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	Technetium (Technetium 99m)IBA 01/2017
1	Androgen Receptors (Androgen Receptor)IBA 01/2017
1	N,N'- bis(2- hydroxy- 5- (ethylene- beta- carboxy)benzyl)ethylenediamine N,N'-diacetic acidIBA 08/2016
1	ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA 05/2016
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2016
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 12/2015
1	ferryl iron (Fe(4+))IBA 01/2013
1	Dihydrotachysterol (AT 10)IBA 01/2013
1	Imatinib Mesylate (Gleevec)FDA Link 01/2013
1	Vasopressins (Vasopressin)IBA 11/2012

Therapy/Procedure

23	Therapeutics 06/2022 - 11/2012
10	Radiotherapy 04/2022 - 01/2019
10	Prostatectomy (Retropubic Prostatectomy) 01/2022 - 12/2018
6	Castration 01/2021 - 01/2017
4	Parathyroidectomy 01/2022 - 01/2016
2	Aftercare (After-Treatment) 04/2022 - 01/2017
2	Lymph Node Excision (Lymph Node Dissection) 11/2021 - 08/2020
2	Liver Transplantation 11/2016 - 01/2016
2	Hepatectomy 11/2016 - 01/2016
1	Replacement Arthroplasty 01/2022
1	Precision Medicine 12/2021
1	Intravenous Administration 01/2021
1	Minimally Invasive Surgical Procedures 08/2020
1	Salvage Therapy 01/2019
1	Boron Neutron Capture Therapy 01/2019